Scientific article

Inhaled nitric oxide for acute respiratory distress syndrome (ards) in children and adults

Published inCochrane Database of Systematic Reviews, no. 6, CD002787
Publication date2016

Acute hypoxaemic respiratory failure (AHRF) and mostly acute respiratory distress syndrome (ARDS) are critical conditions. AHRF results from several systemic conditions and is associated with high mortality and morbidity in individuals of all ages. Inhaled nitric oxide (INO) has been used to improve oxygenation, but its role remains controversial. This Cochrane review was originally published in 2003, and has been updated in 2010 and 2016.

  • Acute Disease
  • Acute Lung Injury/drug therapy/mortality
  • Administration
  • Inhalation
  • Adult
  • Child
  • Humans
  • Hypoxia/drug therapy/mortality
  • Length of Stay
  • Nitric Oxide/administration & dosage/adverse effects
  • Randomized Controlled Trials as Topic
  • Respiratory Distress Syndrome
  • Adult/drug therapy/mortality
  • Respiratory Insufficiency/drug therapy/mortality
  • Vasodilator Agents/adverse effects/therapeutic use
Citation (ISO format)
GEBISTORF, Fabienne et al. Inhaled nitric oxide for acute respiratory distress syndrome (ards) in children and adults. In: Cochrane Database of Systematic Reviews, 2016, n° 6, p. CD002787. doi: 10.1002/14651858.CD002787.pub3
Main files (1)
Article (Published version)
ISSN of the journal1469-493X

Technical informations

Creation09/14/2017 5:02:00 PM
First validation09/14/2017 5:02:00 PM
Update time03/15/2023 2:00:40 AM
Status update03/15/2023 2:00:40 AM
Last indexation01/17/2024 12:39:49 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack